Integrating killer cell immunoglobulin-like receptor high-resolution genotyping for predicting transplant outcomes in allogeneic hematopoietic stem cell transplantation

The success of hematopoietic stem cell transplantation (HSCT) partly relies on the beneficial graft-versus-leukemia effect, mediated by alloreactive NK cells through their killer cell immunoglobulin-like receptors (KIR). Conflicting results have been reported regarding the impact of the KIR immunog...

Full description

Saved in:
Bibliographic Details
Main Authors: Antonia Schäfer, Stéphane Buhler, Ticiana D.J. Farias, Katherine M. Kichula, Helen Baldomero, Zuleika Calderin Sollet, Sylvie Ferrari-Lacraz, Baptiste Micheli, Stavroula Masouridi-Levrat, Vanessa Mesquita, Oliver Kürsteiner, Gayathri Nair, Jörg Halter, Tayfun Güngör, Dominik Schneidawind, Yves Chalandon, Jakob R. Passweg, Paul J. Norman, Jean Villard
Format: Article
Language:English
Published: Ferrata Storti Foundation 2025-07-01
Series:Haematologica
Online Access:https://haematologica.org/article/view/12166
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849429706766548992
author Antonia Schäfer
Stéphane Buhler
Ticiana D.J. Farias
Katherine M. Kichula
Helen Baldomero
Zuleika Calderin Sollet
Sylvie Ferrari-Lacraz
Baptiste Micheli
Stavroula Masouridi-Levrat
Vanessa Mesquita
Oliver Kürsteiner
Gayathri Nair
Jörg Halter
Tayfun Güngör
Dominik Schneidawind
Yves Chalandon
Jakob R. Passweg
Paul J. Norman
Jean Villard
author_facet Antonia Schäfer
Stéphane Buhler
Ticiana D.J. Farias
Katherine M. Kichula
Helen Baldomero
Zuleika Calderin Sollet
Sylvie Ferrari-Lacraz
Baptiste Micheli
Stavroula Masouridi-Levrat
Vanessa Mesquita
Oliver Kürsteiner
Gayathri Nair
Jörg Halter
Tayfun Güngör
Dominik Schneidawind
Yves Chalandon
Jakob R. Passweg
Paul J. Norman
Jean Villard
author_sort Antonia Schäfer
collection DOAJ
description The success of hematopoietic stem cell transplantation (HSCT) partly relies on the beneficial graft-versus-leukemia effect, mediated by alloreactive NK cells through their killer cell immunoglobulin-like receptors (KIR). Conflicting results have been reported regarding the impact of the KIR immunogenetic system on HSCT outcomes with a scarcity of data interrogating the effect of KIR allelic polymorphism. With the aim to fill this gap, donor KIR genes derived from a national cohort of 1247 HLA-matched transplanted donor/recipient pairs were determined at a high-resolution and tested in Cox proportional hazards models. Donor/recipient (D/R) pairs bearing a KIR2DS4*00101 – HLA-C1/C2/A11 interaction showed a significant detrimental impact on progression-free survival (PFS), overall survival (OS), transplant-related mortality (TRM) and chronic graft-versus-host disease (cGvHD) in multivariable analysis. Strong KIR2DL2/L3 – HLAC1 and especially KIR2DL3*00501 and *015 interactions showed a significant increase in the incidence of cGvHD compared to missing ligand D/R pairs. Highly inhibiting KIR3DL1 – HLA-B and HLA-A (Bw4) interactions were associated with a reduced relapse incidence as compared to weak and non-inhibiting interactions. Our study indicates that high-resolution KIR genotyping informs post-transplant outcomes with a seemingly higher protection of educated NK cells.
format Article
id doaj-art-54503a9b488f4a718134eeea724c3f59
institution Kabale University
issn 0390-6078
1592-8721
language English
publishDate 2025-07-01
publisher Ferrata Storti Foundation
record_format Article
series Haematologica
spelling doaj-art-54503a9b488f4a718134eeea724c3f592025-08-20T03:28:17ZengFerrata Storti FoundationHaematologica0390-60781592-87212025-07-01999110.3324/haematol.2024.287061Integrating killer cell immunoglobulin-like receptor high-resolution genotyping for predicting transplant outcomes in allogeneic hematopoietic stem cell transplantationAntonia Schäfer0Stéphane Buhler1Ticiana D.J. Farias2Katherine M. Kichula3Helen Baldomero4Zuleika Calderin Sollet5Sylvie Ferrari-Lacraz6Baptiste Micheli7Stavroula Masouridi-Levrat8Vanessa Mesquita9Oliver Kürsteiner10Gayathri Nair11Jörg Halter12Tayfun Güngör13Dominik Schneidawind14Yves Chalandon15Jakob R. Passweg16Paul J. Norman17Jean Villard18Transplantation Immunology Unit and National Reference Laboratory for Histocompatibility, Department of Diagnostic, Geneva University Hospitals, GenevaTransplantation Immunology Unit and National Reference Laboratory for Histocompatibility, Department of Diagnostic, Geneva University Hospitals, GenevaDepartment of Biomedical Informatics, and Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CODepartment of Biomedical Informatics, and Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CODivision of Hematology, Basel University Hospital, BaselTransplantation Immunology Unit and National Reference Laboratory for Histocompatibility, Department of Diagnostic, Geneva University Hospitals, GenevaTransplantation Immunology Unit and National Reference Laboratory for Histocompatibility, Department of Diagnostic, Geneva University Hospitals, GenevaGenetic Medicine Division, Department of Diagnostic, Geneva University Hospitals, GenevaDivision of Hematology, Department of Oncology, Geneva University Hospitals, GenevaDepartment of Medical Oncology and Hematology, University Hospital Zurich, ZurichSwiss Blood Stem Cells Registry, Blutspende SRK Schweiz, BernSwiss Blood Stem Cells Registry, Blutspende SRK Schweiz, BernDivision of Hematology, Basel University Hospital, BaselDepartment of Stem Cell Transplantation, University Children’s Hospital Zurich, CIC 334, ZurichDepartment of Medical Oncology and Hematology, University Hospital Zurich, ZurichDivision of Hematology, Department of Oncology, Geneva University Hospitals, GenevaDivision of Hematology, Basel University Hospital, BaselDepartment of Biomedical Informatics, and Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, COTransplantation Immunology Unit and National Reference Laboratory for Histocompatibility, Department of Diagnostic, Geneva University Hospitals, Geneva The success of hematopoietic stem cell transplantation (HSCT) partly relies on the beneficial graft-versus-leukemia effect, mediated by alloreactive NK cells through their killer cell immunoglobulin-like receptors (KIR). Conflicting results have been reported regarding the impact of the KIR immunogenetic system on HSCT outcomes with a scarcity of data interrogating the effect of KIR allelic polymorphism. With the aim to fill this gap, donor KIR genes derived from a national cohort of 1247 HLA-matched transplanted donor/recipient pairs were determined at a high-resolution and tested in Cox proportional hazards models. Donor/recipient (D/R) pairs bearing a KIR2DS4*00101 – HLA-C1/C2/A11 interaction showed a significant detrimental impact on progression-free survival (PFS), overall survival (OS), transplant-related mortality (TRM) and chronic graft-versus-host disease (cGvHD) in multivariable analysis. Strong KIR2DL2/L3 – HLAC1 and especially KIR2DL3*00501 and *015 interactions showed a significant increase in the incidence of cGvHD compared to missing ligand D/R pairs. Highly inhibiting KIR3DL1 – HLA-B and HLA-A (Bw4) interactions were associated with a reduced relapse incidence as compared to weak and non-inhibiting interactions. Our study indicates that high-resolution KIR genotyping informs post-transplant outcomes with a seemingly higher protection of educated NK cells. https://haematologica.org/article/view/12166
spellingShingle Antonia Schäfer
Stéphane Buhler
Ticiana D.J. Farias
Katherine M. Kichula
Helen Baldomero
Zuleika Calderin Sollet
Sylvie Ferrari-Lacraz
Baptiste Micheli
Stavroula Masouridi-Levrat
Vanessa Mesquita
Oliver Kürsteiner
Gayathri Nair
Jörg Halter
Tayfun Güngör
Dominik Schneidawind
Yves Chalandon
Jakob R. Passweg
Paul J. Norman
Jean Villard
Integrating killer cell immunoglobulin-like receptor high-resolution genotyping for predicting transplant outcomes in allogeneic hematopoietic stem cell transplantation
Haematologica
title Integrating killer cell immunoglobulin-like receptor high-resolution genotyping for predicting transplant outcomes in allogeneic hematopoietic stem cell transplantation
title_full Integrating killer cell immunoglobulin-like receptor high-resolution genotyping for predicting transplant outcomes in allogeneic hematopoietic stem cell transplantation
title_fullStr Integrating killer cell immunoglobulin-like receptor high-resolution genotyping for predicting transplant outcomes in allogeneic hematopoietic stem cell transplantation
title_full_unstemmed Integrating killer cell immunoglobulin-like receptor high-resolution genotyping for predicting transplant outcomes in allogeneic hematopoietic stem cell transplantation
title_short Integrating killer cell immunoglobulin-like receptor high-resolution genotyping for predicting transplant outcomes in allogeneic hematopoietic stem cell transplantation
title_sort integrating killer cell immunoglobulin like receptor high resolution genotyping for predicting transplant outcomes in allogeneic hematopoietic stem cell transplantation
url https://haematologica.org/article/view/12166
work_keys_str_mv AT antoniaschafer integratingkillercellimmunoglobulinlikereceptorhighresolutiongenotypingforpredictingtransplantoutcomesinallogeneichematopoieticstemcelltransplantation
AT stephanebuhler integratingkillercellimmunoglobulinlikereceptorhighresolutiongenotypingforpredictingtransplantoutcomesinallogeneichematopoieticstemcelltransplantation
AT ticianadjfarias integratingkillercellimmunoglobulinlikereceptorhighresolutiongenotypingforpredictingtransplantoutcomesinallogeneichematopoieticstemcelltransplantation
AT katherinemkichula integratingkillercellimmunoglobulinlikereceptorhighresolutiongenotypingforpredictingtransplantoutcomesinallogeneichematopoieticstemcelltransplantation
AT helenbaldomero integratingkillercellimmunoglobulinlikereceptorhighresolutiongenotypingforpredictingtransplantoutcomesinallogeneichematopoieticstemcelltransplantation
AT zuleikacalderinsollet integratingkillercellimmunoglobulinlikereceptorhighresolutiongenotypingforpredictingtransplantoutcomesinallogeneichematopoieticstemcelltransplantation
AT sylvieferrarilacraz integratingkillercellimmunoglobulinlikereceptorhighresolutiongenotypingforpredictingtransplantoutcomesinallogeneichematopoieticstemcelltransplantation
AT baptistemicheli integratingkillercellimmunoglobulinlikereceptorhighresolutiongenotypingforpredictingtransplantoutcomesinallogeneichematopoieticstemcelltransplantation
AT stavroulamasouridilevrat integratingkillercellimmunoglobulinlikereceptorhighresolutiongenotypingforpredictingtransplantoutcomesinallogeneichematopoieticstemcelltransplantation
AT vanessamesquita integratingkillercellimmunoglobulinlikereceptorhighresolutiongenotypingforpredictingtransplantoutcomesinallogeneichematopoieticstemcelltransplantation
AT oliverkursteiner integratingkillercellimmunoglobulinlikereceptorhighresolutiongenotypingforpredictingtransplantoutcomesinallogeneichematopoieticstemcelltransplantation
AT gayathrinair integratingkillercellimmunoglobulinlikereceptorhighresolutiongenotypingforpredictingtransplantoutcomesinallogeneichematopoieticstemcelltransplantation
AT jorghalter integratingkillercellimmunoglobulinlikereceptorhighresolutiongenotypingforpredictingtransplantoutcomesinallogeneichematopoieticstemcelltransplantation
AT tayfungungor integratingkillercellimmunoglobulinlikereceptorhighresolutiongenotypingforpredictingtransplantoutcomesinallogeneichematopoieticstemcelltransplantation
AT dominikschneidawind integratingkillercellimmunoglobulinlikereceptorhighresolutiongenotypingforpredictingtransplantoutcomesinallogeneichematopoieticstemcelltransplantation
AT yveschalandon integratingkillercellimmunoglobulinlikereceptorhighresolutiongenotypingforpredictingtransplantoutcomesinallogeneichematopoieticstemcelltransplantation
AT jakobrpassweg integratingkillercellimmunoglobulinlikereceptorhighresolutiongenotypingforpredictingtransplantoutcomesinallogeneichematopoieticstemcelltransplantation
AT pauljnorman integratingkillercellimmunoglobulinlikereceptorhighresolutiongenotypingforpredictingtransplantoutcomesinallogeneichematopoieticstemcelltransplantation
AT jeanvillard integratingkillercellimmunoglobulinlikereceptorhighresolutiongenotypingforpredictingtransplantoutcomesinallogeneichematopoieticstemcelltransplantation